Mason JN - Search Results

1

Synthesis and characterization of a pegylated derivative of 3-(1,2,3,6-tetrahydro-pyridin-4yl)-1H-indole (IDT199): a high affinity SERT ligand for conjugation to quantum dots.

Tomlinson ID, Warnerment MR, Mason JN, Vergne MJ, Hercules DM, Blakely RD, Rosenthal SJ. Tomlinson ID, et al. Among authors: mason jn. Bioorg Med Chem Lett. 2007 Oct 15;17(20):5656-60. doi: 10.1016/j.bmcl.2007.07.061. Epub 2007 Aug 21. Bioorg Med Chem Lett. 2007. PMID: 17766114

2

Surface modification to reduce nonspecific binding of quantum dots in live cell assays.

Bentzen EL, Tomlinson ID, Mason J, Gresch P, Warnement MR, Wright D, Sanders-Bush E, Blakely R, Rosenthal SJ. Bentzen EL, et al. Bioconjug Chem. 2005 Nov-Dec;16(6):1488-94. doi: 10.1021/bc0502006. Bioconjug Chem. 2005. PMID: 16287246

3

Labeling cell-surface proteins via antibody quantum dot streptavidin conjugates.

Mason JN, Tomlinson ID, Rosenthal SJ, Blakely RD. Mason JN, et al. Methods Mol Biol. 2005;303:35-50. doi: 10.1385/1-59259-901-X:035. Methods Mol Biol. 2005. PMID: 15923673

4

Peptide-conjugated quantum dots: imaging the angiotensin type 1 receptor in living cells.

Tomlinson ID, Mason JN, Blakely RD, Rosenthal SJ. Tomlinson ID, et al. Among authors: mason jn. Methods Mol Biol. 2005;303:51-60. doi: 10.1385/1-59259-901-X:051. Methods Mol Biol. 2005. PMID: 15923674

5

Inhibitors of the serotonin transporter protein (SERT): the design and synthesis of biotinylated derivatives of 3-(1,2,3,6-tetrahydro-pyridin-4-yl)-1H-indoles. High-affinity serotonergic ligands for conjugation with quantum dots.

Tomlinson ID, Mason JN, Blakely RD, Rosenthal SJ. Tomlinson ID, et al. Among authors: mason jn. Bioorg Med Chem Lett. 2005 Dec 1;15(23):5307-10. doi: 10.1016/j.bmcl.2005.08.030. Epub 2005 Sep 23. Bioorg Med Chem Lett. 2005. PMID: 16183285

6

High affinity inhibitors of the dopamine transporter (DAT): novel biotinylated ligands for conjugation to quantum dots.

Tomlinson ID, Mason JN, Blakely RD, Rosenthal SJ. Tomlinson ID, et al. Among authors: mason jn. Bioorg Med Chem Lett. 2006 Sep 1;16(17):4664-7. doi: 10.1016/j.bmcl.2006.05.097. Epub 2006 Jun 19. Bioorg Med Chem Lett. 2006. PMID: 16784853

7

Quantum dot ex vivo labeling of neuromuscular synapses.

Orndorff RL, Warnement MR, Mason JN, Blakely RD, Rosenthal SJ. Orndorff RL, et al. Among authors: mason jn. Nano Lett. 2008 Mar;8(3):780-5. doi: 10.1021/nl072460x. Epub 2008 Feb 1. Nano Lett. 2008. PMID: 18237149

8

Novel fluorescence-based approaches for the study of biogenic amine transporter localization, activity, and regulation.

Mason JN, Farmer H, Tomlinson ID, Schwartz JW, Savchenko V, DeFelice LJ, Rosenthal SJ, Blakely RD. Mason JN, et al. J Neurosci Methods. 2005 Apr 15;143(1):3-25. doi: 10.1016/j.jneumeth.2004.09.028. Epub 2004 Nov 28. J Neurosci Methods. 2005. PMID: 15763132

9

Desvenlafaxine succinate identifies novel antagonist binding determinants in the human norepinephrine transporter.

Mason JN, Deecher DC, Richmond RL, Stack G, Mahaney PE, Trybulski E, Winneker RC, Blakely RD. Mason JN, et al. J Pharmacol Exp Ther. 2007 Nov;323(2):720-9. doi: 10.1124/jpet.107.125716. Epub 2007 Aug 2. J Pharmacol Exp Ther. 2007. PMID: 17673606

10

Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transporters.

Eshleman AJ, Stewart E, Evenson AK, Mason JN, Blakely RD, Janowsky A, Neve KA. Eshleman AJ, et al. Among authors: mason jn. J Neurochem. 1997 Oct;69(4):1459-66. doi: 10.1046/j.1471-4159.1997.69041459.x. J Neurochem. 1997. PMID: 9326274 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page